查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2088535

動物用藥品市場：2026-2032年全球市場預測（依產品類型、給藥途徑、動物類型、適應症、通路及最終用戶分類）

Veterinary Pharmaceuticals Market by Product Type, Route of Administration, Animal Type, Indications, Distribution Channel, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物用藥品市場將成長至 803.1 億美元，複合年成長率為 8.70%。

主要市場統計數據
基準年 2025 447.8億美元
預計年份：2026年 485.7億美元
預測年份 2032 803.1億美元
複合年成長率 (%) 8.70%

執行摘要簡介

無論是伴侶動物還是肉類，動物用藥品都在從一次性治療轉向數據驅動的預防性動物健康管理。這種轉變的促進因素包括寵物飼養量的增加、蛋白質消費量的上升、人們對通用感染疾病的認知提高，以及對動物福利和食品安全日益嚴格的要求。

動物醫藥的變革

合理使用抗生素、生物製藥創新以及獸醫和寵物飼主位化管道的加速發展，正在重塑動物用藥品的格局。在監管方面，人們呼籲更負責任地使用具有重要醫療價值的抗生素，歐盟第2019/6號法規限制了常規抗生素的使用，而美國食品藥物管理局（FDA）則繼續對具有重要醫療價值的抗生素進行獸醫監管。

人工智慧（AI）的累積影響

人工智慧（AI）正成為動物用藥品研發、生產和上市後監測等各領域的一股實際驅動力。人工智慧驅動的建模能夠實現標靶識別、化合物篩檢和製劑最佳化，並能從不利事件報告、電子健康記錄、診斷影像和真實臨床治療數據中檢測安全訊號。

影響需求的區域趨勢

亞太地區市場需求旺盛，這得益於中國、印度、日本、韓國和澳洲大規模的畜牧業基礎、不斷擴張的水產養殖業以及日益成長的寵物照護需求。聯合國糧食及農業組織（糧農組織）將亞洲定位為全球重要的畜牧業和水產養殖生產中心，疫苗、驅蟲藥、感染疾病物和畜牧健康管理產品在疾病控制和糧食安全方面發揮核心作用。北美地區仍然是重要的市場，這得益於先進的獸醫診所、高水準的寵物醫療保健支出、美國食品藥物管理局（FDA）和加拿大衛生署的嚴格監管，以及對生技藥品、皮膚病學、疼痛管理和驅蟲藥等領域創新研發的持續投入。

針對特定策略群體的洞察

東協地區的需求主要受家禽、生豬、​​水產養殖和伴侶動物市場成長的驅動。鑑於該地區疾病疫情反覆爆發，各國政府正將疾病管制、生物安全和疫苗接種列為優先事項。海灣合作理事會（GCC）成員國雖然規模相對較小，但由於其在高品質伴侶動物照護、馬匹醫療、駱駝健康管理和食品安全方面的投資，具有重要的戰略意義。這些領域都依賴受監管的獸藥和可靠的低溫運輸配送。

各國具體需求趨勢

在美國，高昂的寵物消費、先進的獸醫醫院以及美國食品藥物管理局（FDA）獸醫中心的監管推動了市場需求。在加拿大，監管准入、牲畜健康管理、伴侶動物照護和食品安全是重點關注領域。墨西哥受益於家禽、牛、豬以及跨境貿易趨勢，而巴西仍是動物性蛋白質的主要生產國，對疫苗、驅蟲藥、生殖藥物以及用於提高生產力的療法有著強勁的需求。

為行業領導者提供的實用建議

產業領導者應優先考慮預防醫學、合理使用抗生素以及差異化的伴侶動物產品系列。投資應集中於疫苗、驅蟲藥、皮膚病治療、疼痛管理、生殖健康、生物製藥和長效療法，並與獸醫工作流程和可衡量的臨床結果保持一致。

調查方法

本研究採用系統性的調查方法，結合了二手資料研究、一手資料檢驗和分析三角驗證。資訊來源包括美國食品藥物管理局獸醫中心（FDA CVM）、歐洲藥品管理局（EMA）、美國農業部（USDA）、世界動物衛生組織（WOAH）、聯合國糧農組織（FAO）和各國獸醫主管部門的監管出版刊物、行業資料庫、同行評審文獻、動物衛生政策文件以及權威行業協會的資料。

策略結論

動物用藥品市場正朝著預防為主、監管更嚴格、數位化程度更高、實證主導的方向發展。戰略方向將圍繞著減少牲畜疾病損失、提高伴侶動物生活品質以及支持安全永續的食品體係等需求而展開。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：動物用藥品市場：依產品類型分類

  • 製藥
    • 止痛藥
    • 抗感染藥物
      • 抗生素
      • 抗真菌藥物
      • 抗病毒藥物
    • 抗發炎藥
      • NSAIDs
      • 皮質類固醇
    • 殺蟲劑
    • 麻醉劑
    • 麻藥
  • 藥用飼料添加劑
  • 疫苗
    • 去活化疫苗
    • 減毒活疫苗
    • 重組疫苗

第8章：動物用藥品市場：依給藥途徑分類

  • 注射藥物
    • 肌肉內部
    • 皮下
  • 口服
    • 咀嚼片
    • 懸浮液和糖漿
    • 藥片
  • 外用
    • 噴
    • 粉末
    • 軟膏

第9章：動物用藥品市場：依動物類型分類

  • 伴侶動物
    • 貓
    • 狗
    • 馬
  • 家畜
    • 牛
    • 家禽
    • 綿羊/山羊
    • 豬

第10章：動物用藥品市場：依適應症分類

  • 慢性疼痛和急性疼痛管理
  • 免疫系統疾病
  • 感染疾病
  • 代謝性疾病
  • 神經病變
  • 整形外科疾病
  • 寄生蟲感染疾病
  • 生殖健康

第11章：動物用藥品市場：依通路分類

  • 線上
  • 離線

第12章：動物用藥品市場：依最終用戶分類

  • 畜牧場
  • 寵物飼主
  • 獸醫醫院和診所

第13章：動物用藥品市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章動物用藥品市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章動物用藥品市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 巴基斯坦

第16章：巴基斯坦動物用藥品市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Aurora Pharmaceutical, Inc.
  • Biogenesis Bago SA
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Chanelle Pharma
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation by Mars, Incorporated
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Laboratorio Drag Pharma Chile Invetec SA
  • Merck & Co., Inc.
  • Neogen Corporation
  • Norbrook Group
  • Phibro Animal Health Corporation
  • Teknofarma Srl
  • Vetoquinol Group
  • Vetpharma Animal Health SL by Insud Pharma SLU
  • Virbac SA
  • Zendal Group
  • Zoetis Inc.
Product Code: MRR-032F197B035E

The Veterinary Pharmaceuticals Market is projected to grow by USD 80.31 billion at a CAGR of 8.70% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 44.78 billion
Estimated Year [2026] USD 48.57 billion
Forecast Year [2032] USD 80.31 billion
CAGR (%) 8.70%

Executive Summary Introduction

Veterinary pharmaceuticals are moving from episodic treatment toward preventive, data-enabled animal health management across companion animals and food-producing species. Demand is supported by rising pet ownership, protein consumption, zoonotic disease vigilance, and tighter expectations for animal welfare and food safety.

Verified industry signals reinforce the market's importance. The American Pet Products Association reported U.S. pet industry expenditures of USD 147.0 billion in 2023, while the World Organisation for Animal Health has noted that animal diseases cause at least 20% of global livestock production losses. These facts make vaccines, parasiticides, anti-infectives, analgesics, dermatology therapies, reproductive products, and biologics essential to resilient veterinary care.

Transformative Shifts in Veterinary Pharmaceuticals

The veterinary pharmaceutical landscape is being reshaped by antimicrobial stewardship, biologic innovation, and faster digital routes to veterinarians and animal owners. Regulation is moving toward more responsible use of medically important antimicrobials, with the European Union's Regulation 2019/6 restricting routine antibiotic use and the U.S. FDA maintaining veterinary oversight for medically important antimicrobial drugs.

At the same time, demand is shifting toward preventive portfolios, including vaccines, ectoparasiticides, endectocides, monoclonal antibodies, and long-acting formulations. Supply chains are also changing as companies invest in cold-chain capacity, regional manufacturing, serialization, and pharmacovigilance systems to protect product quality and regulatory trust.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator across veterinary pharmaceutical research, manufacturing, and post-market surveillance. AI-enabled modeling can improve target identification, screen compounds, optimize formulations, and detect safety signals from adverse event reports, electronic medical records, diagnostic images, and real-world treatment data.

The cumulative impact is strongest when AI is governed by validated data pipelines, explainable models, and regulatory-grade documentation. For industry leaders, AI is not a replacement for veterinary clinical evidence; it is a force multiplier that can reduce cycle time, improve pharmacovigilance sensitivity, support precision dosing, and strengthen customer engagement when aligned with FDA, EMA, WOAH, and VICH quality expectations.

Regional Dynamics Shaping Demand

Asia-Pacific is a high-volume arena because of its large livestock base, expanding aquaculture sector, and rising companion animal care in China, India, Japan, South Korea, and Australia. The FAO identifies Asia as a major center of global livestock and aquaculture production, making vaccines, antiparasitics, anti-infectives, and herd-health products central to disease control and food security. North America remains a premium region, supported by advanced veterinary clinics, high pet healthcare spending, strong FDA and Health Canada oversight, and continued investment in biologics, dermatology, pain management, and parasiticide innovation.

Latin America is anchored by Brazil and Mexico, where poultry, cattle, swine, and companion animal demand support broad veterinary pharmaceutical use. Europe is defined by EMA governance, Regulation 2019/6, antimicrobial stewardship, and high vaccine adoption, while the Middle East is investing in food security, equine health, camel health, and companion animal services. Africa presents long-term need for vaccines, antiparasitics, and cold-chain access, as WOAH and FAO continue to emphasize livestock health as central to rural livelihoods, zoonotic disease control, and sustainable food systems.

Strategic Group Insights

ASEAN demand is supported by poultry, swine, aquaculture, and companion animal growth, with governments emphasizing disease control, biosecurity, and vaccination after repeated regional outbreaks. The GCC is comparatively smaller but strategically important because of premium companion animal care, equine medicine, camel health, and food-security investments that depend on regulated veterinary inputs and reliable cold-chain distribution.

The European Union is a global reference point for pharmacovigilance, antimicrobial restrictions, residue control, and quality standards under EMA-led processes. BRICS countries combine scale and production intensity, especially in China, India, and Brazil, where livestock, aquaculture, and companion animal care create sustained need for vaccines, parasiticides, reproductive products, and anti-infectives. G7 markets lead in innovation, biologics, compliance, and pet therapeutics, while NATO countries overlap heavily with mature regulated markets, making supply resilience, biosecurity, and emergency preparedness important considerations for animal health security.

Country-Level Demand Signals

The United States is driven by high pet spending, advanced veterinary hospitals, and FDA Center for Veterinary Medicine oversight, while Canada emphasizes regulated access, herd health, companion animal care, and food safety. Mexico benefits from poultry, cattle, swine, and cross-border trade dynamics, and Brazil remains a major animal protein producer with strong demand for vaccines, parasiticides, reproductive medicines, and productivity-supporting therapies.

In Europe, the United Kingdom, Germany, France, Italy, and Spain are mature veterinary pharmaceutical markets shaped by pet humanization, livestock biosecurity, vaccine uptake, and strict medicine controls, while Russia retains demand across food animals and companion animals despite supply-chain complexity. China and India offer scale in livestock, aquaculture, and companion animals, Japan and South Korea emphasize premium veterinary care, companion animal therapeutics, and innovation, Australia prioritizes biosecurity, ruminant health, and parasiticide use, and Pakistan shows continued need for affordable livestock pharmaceuticals, vaccine access, and stronger veterinary distribution.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize preventive medicine, antimicrobial stewardship, and differentiated companion animal portfolios. Investment should focus on vaccines, parasiticides, dermatology, pain management, reproductive health, biologics, and long-acting therapies that align with veterinarian workflow and measurable clinical outcomes.

Companies should strengthen regulatory intelligence, local market access, cold-chain execution, product serialization, and post-market safety systems. AI should be deployed for drug discovery, demand planning, pharmacovigilance, quality monitoring, and field-force effectiveness, but only with auditable datasets, cybersecurity safeguards, explainable models, and human veterinary oversight.

Research Methodology

The research applies a structured methodology combining secondary research, primary validation, and analytical triangulation. Sources include regulatory publications from FDA CVM, EMA, USDA, WOAH, FAO, national veterinary authorities, trade databases, peer-reviewed literature, animal health policy documents, and recognized industry associations.

Insights are validated by comparing demand indicators, disease burden, policy changes, product approvals, animal population trends, pharmacovigilance signals, and channel dynamics. The approach emphasizes verified evidence, transparent assumptions, and cross-regional consistency to support executive decision-making in veterinary pharmaceuticals without relying on market sizing, market share, or forecasting.

Strategic Conclusion

The veterinary pharmaceuticals market is becoming more preventive, regulated, digital, and evidence-led. Strategic direction will be shaped by the need to reduce disease-related livestock losses, improve companion animal quality of life, and support safe, sustainable food systems.

Organizations that combine scientific innovation with antimicrobial stewardship, regional execution, AI-enabled intelligence, and trusted veterinary relationships will be best positioned. The most durable advantage will come from portfolios that deliver measurable animal health outcomes while meeting rising expectations for safety, access, quality, and regulatory compliance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Pharmaceuticals Market, by Product Type

  • 7.1. Drugs
    • 7.1.1. Analgesics
    • 7.1.2. Anti-Infectives
      • 7.1.2.1. Antibiotics
      • 7.1.2.2. Antifungals
      • 7.1.2.3. Antivirals
    • 7.1.3. Anti-Inflammatories
      • 7.1.3.1. NSAIDs
      • 7.1.3.2. Corticosteroids
    • 7.1.4. Parasiticides
    • 7.1.5. Anaesthetics
    • 7.1.6. Anesthetic
  • 7.2. Medicated Feed Additives
  • 7.3. Vaccines
    • 7.3.1. Inactivated Vaccines
    • 7.3.2. Live Attenuated Vaccines
    • 7.3.3. Recombinant Vaccines

8. Veterinary Pharmaceuticals Market, by Route of Administration

  • 8.1. Injectable
    • 8.1.1. Intramuscular
    • 8.1.2. Subcutaneous
  • 8.2. Oral
    • 8.2.1. Chews
    • 8.2.2. Liquid Suspension & Syrup
    • 8.2.3. Tablets
  • 8.3. Topical
    • 8.3.1. Sprays
    • 8.3.2. Powders
    • 8.3.3. Ointments

9. Veterinary Pharmaceuticals Market, by Animal Type

  • 9.1. Companion Animals
    • 9.1.1. Cats
    • 9.1.2. Dogs
    • 9.1.3. Horses
  • 9.2. Livestock Animals
    • 9.2.1. Cattle
    • 9.2.2. Poultry
    • 9.2.3. Sheep & Goats
    • 9.2.4. Swine

10. Veterinary Pharmaceuticals Market, by Indications

  • 10.1. Chronic & Acute Pain Management
  • 10.2. Immunological Conditions
  • 10.3. Infectious Diseases
  • 10.4. Metabolic Disorders
  • 10.5. Neurological Disorders
  • 10.6. Orthopedic Disorders
  • 10.7. Parasitic Infections
  • 10.8. Reproductive Health

11. Veterinary Pharmaceuticals Market, by Distribution Channel

  • 11.1. Online
  • 11.2. Offline

12. Veterinary Pharmaceuticals Market, by End User

  • 12.1. Animal Farms
  • 12.2. Pet Owners
  • 12.3. Veterinary Hospitals & Clinics

13. Veterinary Pharmaceuticals Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Veterinary Pharmaceuticals Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Veterinary Pharmaceuticals Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea
  • 15.16. Pakistan

16. Pakistan Veterinary Pharmaceuticals Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Aurora Pharmaceutical, Inc.
  • 18.2. Biogenesis Bago S.A.
  • 18.3. Biovac Ltd.
  • 18.4. Boehringer Ingelheim International GmbH
  • 18.5. Ceva Sante Animale
  • 18.6. Chanelle Pharma
  • 18.7. China Animal Husbandry Industry Co., Ltd.
  • 18.8. Dechra Pharmaceuticals PLC
  • 18.9. ECO Animal Health Group PLC
  • 18.10. Elanco Animal Health Incorporated
  • 18.11. Heska Corporation by Mars, Incorporated
  • 18.12. Hester Biosciences Limited
  • 18.13. Indian Immunologicals Ltd.
  • 18.14. Intas Pharmaceuticals Ltd.
  • 18.15. Laboratorio Drag Pharma Chile Invetec S.A.
  • 18.16. Merck & Co., Inc.
  • 18.17. Neogen Corporation
  • 18.18. Norbrook Group
  • 18.19. Phibro Animal Health Corporation
  • 18.20. Teknofarma S.r.l.
  • 18.21. Vetoquinol Group
  • 18.22. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • 18.23. Virbac S.A.
  • 18.24. Zendal Group
  • 18.25. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY PHARMACEUTICALS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY PHARMACEUTICALS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY PHARMACEUTICALS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY PHARMACEUTICALS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VETERINARY PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. PAKISTAN VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANALGESICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANALGESICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANALGESICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTIFUNGALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANTIFUNGALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTIFUNGALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANTIVIRALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTIVIRALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANTIVIRALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTI-INFLAMMATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NSAIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NSAIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NSAIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CORTICOSTEROIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PARASITICIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PARASITICIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANAESTHETICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANAESTHETICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANAESTHETICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANESTHETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANESTHETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANESTHETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICATED FEED ADDITIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICATED FEED ADDITIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICATED FEED ADDITIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RECOMBINANT VACCINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAMUSCULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAMUSCULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAMUSCULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ORAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ORAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CHEWS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CHEWS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CHEWS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LIQUID SUSPENSION & SYRUP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LIQUID SUSPENSION & SYRUP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LIQUID SUSPENSION & SYRUP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TABLETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SPRAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SPRAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SPRAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL POWDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL OINTMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL OINTMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL OINTMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HORSES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HORSES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CHRONIC & ACUTE PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CHRONIC & ACUTE PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CHRONIC & ACUTE PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL IMMUNOLOGICAL CONDITIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL IMMUNOLOGICAL CONDITIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL IMMUNOLOGICAL CONDITIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEUROLOGICAL DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ORTHOPEDIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL FARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL FARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL FARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL PET OWNERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PET OWNERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL PET OWNERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 228. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 230. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 232. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 247. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 248. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 249. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 270. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 271. ASEAN VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 275. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 276. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 277. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 278. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 279. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 280. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 281. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 282. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 284. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 285. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 286. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. GCC VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 300. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 302. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 316. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 317. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 318. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 321. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 323. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 324. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 325. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 326. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 327. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 328. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 329. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 330. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 332. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 333. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 334. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 335. G7 VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 336. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 337. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 338. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 339. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 340. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 341. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 342. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 343. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
  • TABLE 344. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
  • TABLE 345. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
  • TABLE 346. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 347. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 348. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 349. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY INDICATIONS, 2018-2032 (USD MILLION)
  • TABLE 350. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 351. NATO VETERINARY PHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 352. GLOBAL VETERINARY PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 353. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 354. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 355. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY DRUGS, 2018-2032 (USD MILLION)
  • TABLE 356. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 357. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORIES, 2018-2032 (USD MILLION)
  • TABLE 358. UNITED STATES VETERINARY PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 359. UNITED STATES VETE